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Abstract
Background: Most cancer cells, in contrast to normal differentiated cells, rely on aerobic glycolysis instead of
oxidative phosphorylation to generate metabolic energy, a phenomenon called the Warburg effect.
Model: Quantum metabolism is an analytic theory of metabolic regulation which exploits the methodology of
quantum mechanics to derive allometric rules relating cellular metabolic rate and cell size. This theory explains
differences in the metabolic rates of cells utilizing OxPhos and cells utilizing glycolysis. This article appeals to an
analytic relation between metabolic rate and evolutionary entropy - a demographic measure of Darwinian fitness -
in order to: (a) provide an evolutionary rationale for the Warburg effect, and (b) propose methods based on
entropic principles of natural selection for regulating the incidence of OxPhos and glycolysis in cancer cells.
Conclusion: The regulatory interventions proposed on the basis of quantum metabolism have applications in
therapeutic strategies to combat cancer. These procedures, based on metabolic regulation, are non-invasive, and
complement the standard therapeutic methods involving radiation and chemotherapy
Background
Cancer is an age-dependent disease characterized by five
key hallmarks in cell physiology that drive the progres-
sive change of normal differentiated cells into diverse
states of malignancy [1]: autonomous growth-replication
in the absence of growth signals; insensitivity to anti-
growth signals; apoptosis-evasion of programmed cell
death, angiogenesis-the induction of the growth of new
blood vessels; invasion and metastasis
The age-dependency of cancer [2] and the relatively
rare incidence of the disease during an average human
life time suggest that adaptive mechanisms exist in cells
and tissues to prevent this multi-step transition from a
normal differentiated cell into malignancy. Conse-
quently, each of these physiological changes constitutes
the rupture of anti-tumor defences developed during the
evolutionary history of the organism. It may be worth
observing that a graph of the logarithm of the total can-
cer incidence against age approximates to a straight line
with a gradient of 6-7 (the value of the power-law expo-
nent) suggesting that 6-7 separate events are required
for neoplastic transformation of a ‘typical’ human cell
[3].
Cancer cells may be considered as autonomous units
which have an impaired capacity to maintain the meta-
bolic stability of the organism in which they reside.
Anti-cancer therapies are corrective measures designed
to remedy this impairment by eliminating the errant
cells.The nature of these corrective measures has under-
gone a significant development, starting with surgical
resection of solid tumors followed by radiation and then
chemotherapy, as the understanding of the biology of
cancer has increased. The non-surgical therapies which
came to dominate the treatment of the disease were
based on the proposition that the disease is primarily
the result of dynamic changes in the genome. This gene
oriented perspective led to the notion that decoding the
genetic instruction that determines the cancer pheno-
type would elucidate its origin and thus provide an
effective biological basis for therapy. Genes represent
the blueprint for phenotypic expression. Accordingly,
the genetic model entailed therapies based on the com-
plete elimination of cancer cells. Radiation and che-
motherapy were the first class of anti-cancer strategies
which this model invoked. These two therapeutic meth-
ods were designed to eliminate cancer cells from tissues.
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non-cancer cells are also killed or damaged leading to
severe side effects.
The next generation of cancer drugs which developed
from this genomic viewpoint explicitly recognized the
multi-step progression towards malignancy, and that in
most instances death only occurs when the metastatic
state is attained. Metastasis is often triggered by angio-
genesis, the proliferation of a network of blood vessels
that penetrates into cancerous tissue, supplying nutri-
ents and oxygen [4].
Drugs that impede the formation of tumor blood ves-
sels were therefore proposed as therapeutic agents in
the combat against malignancy [5]. There exist, how-
ever, some disadvantages to this mode of therapy as
angiogenic inhibitors sometimes trigger side effects and
induce a more invasive type of tumor [6].
Studies in recent years have led to a re-evaluation of
the genomic model of cancer and the development of a
model based on cell metabolism [7]. The research which
triggered this shift from genes to metabolic reactions
was done in 1924 by Warburg [8] who recognized cer-
tain critical differences between energy regulation in
normal differentiated cells and cancer cells. Warburg
analyzed the ratio of oxidative phosphorylation
(OxPhos) to glycolysis in different tissues of cancer cells
and normal cells. Glycolysis under aerobic conditions
was found to be particularly high in aggressive tumors
when compared with benign tumors and normal tissues.
These observations led Warburg to propose deficiency
in OxPhos and elevated glycolysis as the primary cause
of cancer.
The discovery of the double helix by Watson and
Crick in 1953 and its implications for the understanding
of molecular processes in biology diverted interest away
from research into the significance of Warburg’sm e t a -
bolic hypothesis. However, the failure of the genomic
approach to provide effective therapies for certain types
of aggressive cancer, and recent studies [7] creating a
rapprochement of genetic and metabolic views have
revived interest in the Warburg hypothesis.
The hypothesis, in its simplest form, asserts that cancer
is primarily a disease of metabolic dysregulation: a switch,
inducible by various agents- genetic, nutritional and envir-
onmental, from an OxPhos pathway to a glycolytic mode
of energy processing. This focus on metabolism as the pri-
mary cause for the progressive transition from normalcy
to malignancy suggests a radically new approach to cancer
therapy. The focus is to influence metabolic regulation in
cancer cells so that the autonomy, proliferative capacity,
invasiveness and metastasis which define the aggressive
cancer phenotype, is never attained.
A therapeutic strategy which emphasizes containment
rather than annihilation is a radical departure from
methods designed to eradicate cancer cells completely
from tissues. Therapies based on metabolic interventions
involve two complementary programs: the down-regula-
tion of glycolysis and the up-regulation of OxPhos.
According to Warburg the aggressiveness of a tumor
derives from the elevation of the glycolytic mode of
energy processing. This elevation is considered to be the
result of competition between cells utilizing the glycoly-
tic mode, and cells adopting OxPhos. Hence, the princi-
ple that underlies these complementary programs of
disease control is Darwinian: the modulation of the
selective advantage of cells using glycolysis and OxPhos,
respectively.
It is well known that ATP generation through glycoly-
sis is less efficient than through mitochondrial respira-
tion. Hence a long-standing paradox is how cancer cells
with their metabolic disadvantage can survive the com-
petition with normal cells. In terms of biochemical reac-
tions [9], mitochondrial respiration defects lead to
activation of the Akt survival pathway through a
mechanism mediated by NADH. Respiration-deficient
cells harboring mitochondrial defects exhibit depen-
dency on glycolysis, increased NADH, and activation of
Akt, leading to survival advantage and also drug resis-
tance in hypoxia [9].
The efforts to implement these therapeutic programs
have generated certain significant questions regarding
the analytical characterization of Darwinian fitness, the
capacity of a cell type to displace related types in com-
petition for resources. The problem can be formulated
as follows: (a) What class of physiological, biochemical
and biophysical properties of cells confers a selective
advantage during evolution of the cancer phenotype? (b)
To what extent can these properties be analytically
described in terms of bio-energetic and kinetic variables
associated with the regulatory circuits that describe the
metabolic networks?
These questions are consistent with the view that can-
cer development proceeds according to an evolutionary
process in which a succession of genetic and epigenetic
changes, due to the selective advantage conferred, leads
to the progressive transformation of normal cells to can-
cer cells [10-12]. The resolution of the problems
addressed in (a) and (b) would evidently provide an ana-
lytic framework for cancer therapy based on contain-
ment rather than eradication. The analysis would also
yield a rationale based on natural selection for War-
burg’s hypothesis, and consequently, an evolutionary
understanding of the origin of cancer.
The analytical framework for a theory of metabolic
regulation in cells capable of addressing problems of cel-
lular adaptation and somatic evolution within living
organism was proposed in a series of articles [13,14],
and called Quantum Metabolism in view of the
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Quantum Metabolism gives a molecular level explana-
tion of certain empirically derived allometric laws relat-
ing metabolic rate with cell size.
The allometric rules are of the form [14]:
PW
dd 
 
/( ) 1 (1)
Here, P is the metabolic rate, the rate of ATP produc-
tion, W the cell size. The dimensionality parameter d in
the scaling exponent, b = d/(d+1), describes the number
of degrees of freedom of the enzymes which catalyze the
redox reactions within the energy transducing orga-
nelles: mitochondria (in the case of OxPhos), metabolo-
somes (in the case of glycolysis). The proportionality
constant, a, depends on the mode of coupling between
the electron transport chain and ADP phosphorylation.
This mode of coupling is electrical in the case of
OxPhos and chemical in the case of glycolysis.
A mathematical theory of evolution by natural selec-
tion which, for the first time, considered the effect of
resource constraints and finite population size on the
outcome of competition between related types, was
described in [15]. The cornerstone of this model was
the statistical parameter, evolutionary entropy, a mea-
sure of the stability of population numbers, and an
index of Darwinian Fitness.
In this article we will integrate Quantum Metabolism
with certain analytic relations between evolutionary
entropy and metabolic rate to show that selective advan-
tage in cellular evolution is contingent on the resource
constraints - its abundance and distribution and pre-
dicted by the metabolic rate, the rate at which cells
transform resources into metabolic work. Quantum
Metabolism predicts that the metabolic rate of cells uti-
lizing OxPhos and cells utilizing glycolysis will have the
same scaling exponents but will differ in terms of the
proportionality constants. We will exploit this predic-
tion, and the characterization of selective advantage in
terms of resource constraints and metabolic rate, to pro-
vide an evolutionary rationale for the cancer phenotype.
The evolutionary argument rests on differences in the
metabolic rate of cells utilizing OxPhos and glycolytic
pathways, respectively. Cellular metabolic rate can be
influenced by perturbing the geometry of the metabolic
network or the mode of coupling hence the incidence of
OxPhos and glycloysis in normal and cancer cells can
be metabolically regulated. We will appeal to these
notions of metabolic intervention to propose anti-cancer
strategies based on arresting the transformation from a
benign tumor, to a malignant tissue, characterized by
enhanced glycolysis.
This article will give a brief account of Quantum
Metabolism and the scaling laws for metabolic rate
which the new theory derives. We discuss the evolution-
ary perspective this theory entails, and then apply the
new class of models to propose therapies based on alter-
ing the selective advantage of normal and cancer cells
during the transition to the cancer phenotype.
Quantum metabolism
Cellular metabolism is the totality of all chemical reac-
tions in cells carried out by an organism. The character-
istics of living organisms, such as their growth, the
maintenance of their structure and mass transport,
depend on the input of energy from the environment.
Metabolism designates the series of chemical reactions
that transform substrates such as glucose into cellular
building blocks and energy in the form of ATP. A quan-
titative understanding of the rules which regulate this
energy transformation is critical for a quantitative char-
acterization of the selective advantage associated with
different modes of energy processing.
Quantum Metabolism exploits the methodology of the
quantum theory of solids, as developed by Einstein and
Debye, to derive a class of analytic rules relating meta-
bolic rate, with cell size. The variables which define
these rules are bio-energetic parameters, whose values
depend on the phospholipid composition of the bio-
membranes, and enzymatic reaction rates, which depend
on the concentration of substrates in metabolic
reactions.
The allometric laws of metabolism
Metabolic rate, the rate at which an organism trans-
forms nutrients into thermal energy and biological work
required for sustaining life, is highly dependent on the
organism’s size. This observation draws in large part
from the experimental studies of Lavoisier and Laplace
who were the first to demonstrate the relationship
between combustion and respiration. The systematic
empirical study of the relation between metabolic rate,
P, and body size, W, which began with Rubner [16], and
was extended later by Kleiber [17] for non-domesticated
mammals, and by Hemmigsen [18] to uni-cells led to a
set of allometric laws relating metabolic rate with body
size.
Quantum Metabolism exploits the formalism of quan-
tum mechanics to study the dynamics of energy flow in
the electron transfer chain in cells, and provides a mole-
cular level explanation of the empirical rules documen-
ted in Kleiber [17] and Hemmingsen [18].
The derivation of Eq. (1) is based on the assumption
that the transformation of nutrients into thermal energy
and biological work involves the inter-conversion of two
forms of energy [19,20]:
(1) The redox potential difference that is the actual
redox potential between the donor and acceptor couples
in the electron transport chain.
(2) The phosphorylation potential for ATP synthesis.
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characterizes the number of degrees of freedom of the
enzymes which are embedded in the energy transducing
organelles. Enzymatic reactions have an intrinsic direc-
tion and the enzymes localized in the organelles have a
given orientation. The enzymes are subject to oscilla-
tions, due to the redox potential. We will assume that
these vibrations can be approximated by harmonic oscil-
lators. We will also assume that the enzymatic vibra-
tions are coupled and inherited by the energy
transducing organelles in which the enzymes reside.
T h e r ee x i s t sad i v e r s eb o d yo fe m p i r i c a ls u p p o r tf o r
these assumptions. Some of this support can be anno-
tated as follows. Experimental studies of the organiza-
tion of mitochondrial networks show that these systems
can be regarded as coupled oscillators [21].
Synchronisation of metabolic cycles through gene and
enzyme regulation within and between cells has been
shown to involve co-ordinated transcriptional cycles not
only in cultured yeast but also importantly in mamma-
lian cells [22-24]. Tsong and collaborators have demon-
strated that dynamical processes govern the function of
metabolic enzymes which can capture and transmit
energy from oscillating electric fields [25] involving elec-
tro-conformational coupling [26] and electric modula-
tion of membrane proteins [27].
Our model rests on the hypothesis that the metabolic
energy of the cell is characterized by the coupled oscilla-
tions of the energy transducing organelles. Conse-
quently, there are three levels of metabolic organization
to be considered: (a) the energy contained in the vibra-
tions at the level of individual enzymes, (b) the coupling
of the enzymes within the organelles, and (c) the cou-
pling of the energy transducing organelles within the
cell.
Because the energy which drives the process of meta-
bolic regulation depends on coupling at two distinct
levels, the enzymatic level and the level of the energy
transducing organelles, we can assume that the dimen-
sionality parameter d will depend on physico-chemical
properties of the cellular matrix at: (a) the level of the
enzymes, (b) the level of the mitochondria and metabo-
losomes. Hence, we can assume that d, an index of the
number of degrees of freedom of the enzymes aligned in
the organelles, may not satisfy the condition 1<d<3, as
in the Debye model, but may vary in principle between
1 and infinity.
Cycle time and metabolic rate
Quantum Metabolism establishes that the mode of
energy transfer may either be quantized or classical,
contingent on: (a) the cycle time, τ, of the metabolic
p r o c e s s e st r a n s f o r m i n gs u b s t r a t e si n t op r o d u c t sw i t h i n
the network of chemical reactions, and (b) the relaxation
time, τ *, which describes the return time of enzyme
concentrations to their steady state condition after a
random perturbation.
The mean cycle time, τ,i sh i g h l yd e p e n d e n to nt h e
external resources, their concentration and diversity,
whereas the relaxation time, τ*, depends on the density
of the metabolic enzymes and the physical properties of
cellular medium [14].
The mean cycle time is the mean turnover time of the
enzymes in the reaction process. Based on typical data
for ion pumps in biological membranes, the range of
values expected for τ is between 10
-6sa n d1 0
-3s [27,28].
Recently, the proton-driven ATP synthase rotor has
been reported to have Ohmic conductance on the order
of 10 fS [29]. Hence, we can estimate for this value the
number of protons involved in each cycle to range from
10 at the high frequency limit to 10, 000 at the low-fre-
quency limit. More recent papers provided a novel
description of mitochondria as individual oscillators
whose dynamics may obey collective, network properties
in terms of high-amplitude, self-sustained and synchro-
nous oscillations of bio-energetic parameters under both
physiological and patho-physiological conditions [30].
This was demonstrated through the analysis of their
p o w e rs p e c t r u mt h a te x h i b i t sa ne x p o n e n tv a s t l yd i f f e r -
ent from random behavior. Therefore, a proposed
description of the metabolic activity involving mitochon-
drial proteins as coupled quantum oscillators of the
Debye type appears to be supported by recent
observations.
According to Quantum Metabolism, the quantized or
classical modes of energy transfer are determined by the
extreme values assumed by the ratio τ/τ*. We have the
following two scenarios [14]:
(a) When τ <<τ * ,t h em o d eo fe n e r g yt r a n s f e ri sd i s -
crete and the dynamic of energy flow is described by
quantum laws. In this case d is finite and the scaling
exponent, b, satisfies 1/2 <b <1 .
(b) When τ >>τ*, energy transduction is continuous
and the dynamic of energy transfer is described by clas-
sical laws. Here, the parameter d is infinite and the scal-
ing exponent b = 1.
Proportionality constant and metabolic rate
The proportionality constant, a, is determined by the
mechanism - electrical or chemical - which describes
the coupling between electron transfer and ATP assem-
bly. The coupling between the electron transport chain
and ADP phosphorylation is electrical, in the case of
OxPhos, and chemical in the case of glycolytic pro-
cesses. The metabolic rate in cells utilizing each of these
processes will differ, the difference being due to the pro-
portionality constant.
(I) Oxidative phosphorylation.O x P h o si sam o d eo f
energy processing whereby the cell carries out phos-
phorylation of ADP during the oxygen-dependent
Demetrius et al. Theoretical Biology and Medical Modelling 2010, 7:2
http://www.tbiomed.com/content/7/1/2
Page 4 of 12transmission of electrons down the respiratory chain in
the relevant membrane. This reaction produces NADH
which then fuels OxPhos to maximize ATP production
with minimal production of lactate. The coupling
between the electron transport chain and ADP phos-
phorylation is generated by the flow of protons across
the bio-membrane. The proportionality constant a is a
function of the bio-energetic parameters, proton con-
ductance C, and the proton motive potential Δp.T h e s e
parameters will depend on the phospholipid composi-
tion of the membrane [31].
(IIa) Anaerobic glycolysis (glycolysis which is sup-
pressed by oxygen). Anaerobic glycolysis describes a
mode of energy generation when oxygen is supply lim-
ited. In this process, cells direct the pyruvate generated
by glycolysis away from the mitochondrial OxPhos path-
way. This is achieved by generating lactate. This process
does not occur within the mitochondria but in the
liquid protoplasm of the cell. This generation of lactate
allows glycolysis to continue but results in a lowered
ATP production rate. The rate-limiting factors for net
ATP production are the efficiencies of glucose delivery
and lactate removal.
(IIb) Aerobic glycolysis (glycolysis, which is not sup-
pressed by oxygen). Aerobic glycolysis refers to the con-
version of glucose to pyruvate and then to lactate
regardless of whether oxygen is present or not. This
process is also localized in the liquid cytoplasm. This
property is shared by normal proliferative tissue.
The proportionality constant in both aerobic and
anerobic glycolysis is a function of the activity of the
glycolytic enzymes.
We wish to mention that the terms aerobic and anaero-
bic glycolysis are imprecise, although they have been used
extensively in the literature (see for example [12]). The
term aerobic glycolysis is somehow misleading since both
types of glycolysis are in fact anaerobic. Warburg used
the term aerobic glycolysis to emphasize the important
difference from normal glycolysis that it is not sup-
p r e s s e db yo x y g e n .A n yt y p eo fg l y c o l y s i si sa l w a y ss u b -
stantially the same pathway. It runs much faster in the
absence than in the presence of oxygen because of feed-
back regulation. For example, when oxygen is available,
the highly efficient ADP-phosphorylating system in the
energy-transducing bio-membrane ensures a high ATP/
AMP ratio in the cell, which down-regulates the glycoly-
tic enzymes. The distinction between aerobic and anaero-
bic glycolysis is therefore only one of net flux rate.
Consequently, some researchers consider the distinction
redundant. Glycolysis is not oxygen-dependent; but it is
always (partly) suppressed by oxygen.
An empirical observation
Quantum Metabolism predicts that the range of values
assumed by the scaling exponent, b, b<1 (an allometric
relation), b = 1 (an isometry), is highly dependent on
the cycle time, τ, a quantity which varies with the
resource flux - an environmentally regulated property.
This observation indicates that changes in environmen-
tal factors can induce significant changes in the scaling
exponent with concomitant changes in metabolic rate.
Empirical support for this prediction is given in Nakaya
et. al [32]. The experiments in [32], reported a shift
from a scaling law with b = 3/4.t oas c a l i n gl a w
described by b = 1, contingent on changes in the envir-
onmental conditions. The existence of such environ-
mental switches is particularly pertinent in applications
of quantum metabolism to somatic evolution. Such
changes in the scaling exponent indicate a mechanism
for regulating the metabolic profile of cells by imposing
various environmental constraints.
Oxidative phosphorylation and glycolysis: a bio-energetic
comparison
Quantum Metabolism predicts that the scaling laws for
cells utilizing OxPhos and glycolysis will be described by
similar scaling exponents but different proportionality
constants. The proportionality constant is determined
by the mode of coupling between the electron transport
chain and ADP phosphorylation. In OxPhos coupling is
achieved by a single common intermediate between the
oxidation of a variety of substrates and ATP formation.
This intermediate is the trans-membrane proton gradi-
ent. For glycolysis, there is a single set of enzymes for
every coupled reaction.
The differences in the mode of coupling entail signifi-
cant differences in the metabolic efficiency of cells uti-
lizing OxPhos and cells using glycolysis. With glucose as
substrate, OxPhos generates about 17 times more ATP
than glycolysis. Consequently, the metabolic rate of
OxPhos (the respiration rate) will also be greater than
the metabolic rate of glycolysis (the fermentation rate).
The evolutionary history of the different modes of
energy production will provide some perspective on the
selective advantage which respiration and fermentation
conferred as the environmental conditions and resource
constraints changed during the history of life on Earth.
The fermentative way of energy generation is now
accepted as the primordial mode of energy processing
[33]. The invention of photosynthesis changed the atmo-
sphere, since bacteria and plants used light energy to
split water into hydrogen and oxygen. After accumula-
tion of oxygen in the atmosphere, OxPhos as a new way
of energy generation was established by bacteria. Such
free living bacteria have been integrated into eukaryotic
cells and represent the symbiosis of two different cell
types. By acquiring bacteria capable of OxPhos a new
organism emerged having the choice between energy
release based on substrate phosphorylation or OxPhos.
During evolution of higher vertebrates duplication and
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generation which is not suppressed by oxygen [8]. Since
this type of glycolysis is performed even in the presence
of oxygen, Warburg called it aerobic glycolysis. The
term aerobic glycolysis is somehow misleading since
both types of glycolysis are anaerobic. Warburg’st e r m
aerobic glycolysis tries to emphasize the fact that the
important difference to normal glycolysis is that it is not
suppressed by oxygen.
These observations suggest that in the course of evo-
lution, anaerobic glycolysis arose first. The primitive
nature of glycolysis, in contrast to OxPhos, is indicated
by the fact that the glycolytic enzymes exist free in solu-
tion in the soluble portion of the cytoplasm. This is in
sharp contrast to the enzyme systems responsible for
respiration and photosynthesis. These enzymes are
grouped and arranged in an intracellular structure orga-
nized in the mitochondria and chloroplasts [20].
Modes of energy processing: their incidence
Most cancer cells have an increased glycolysis. However,
the relative contribution of glycolysis to ATP supply var-
ies considerably with the tissue. The dependence of gly-
colytic contribution on tissue type is shown in Table 1
[19]. Aerobic glycolysis is also observed in certain nor-
mal cells. A selected group is given in Table 2[19].
In humans, aerobic glycolysis is extremely important
in cells like neurons, retinal cells, stem cells and germ
cells. Neurons, for example, depend absolutely on glu-
cose as an energy source and cannot function anaerobi-
cally. The utility of anaerobic glycolysis, to a muscle cell
for example, when it needs to utilize large amounts of
energy in a short period of time, stems from the fact
that the rate of ATP production from glycolysis is
approximately 100 times faster than from oxidative
phosphorylation. During exertion muscle cells do not
need to activate anabolic reaction pathways. The
requirement is to generate the maximum amount of
ATP, for muscle contraction, in the shortest time frame.
This is the reason why muscle cells derive almost all of
the ATP consumed during exertion from anaerobic gly-
colysis. As these types of cells do not display the cancer
phenotype, it is evident that elevated glycolysis is not a
sufficient condition for tumorigenesis.
Elevated glycolysis is also not always observed at all
stages of tumorigenesis. The studies reported in de
Groof et. al. [34] based on transformed fibroblasts in
mice, indicate the multi-step nature of the progression
from normalcy to the malignant state. These studies
document a high rate of OxPhos in newly transformed
cells with a subsequent high glycolytic rate in the malig-
nant state. The experimental system shows that the pro-
liferation of malignant cells hinges on the evolution of
different metabolic profiles as an adaptive response to
the changes in the resource conditions during the tran-
sition from normal to malignant cells.
We will now show how these evolutionary changes in
metabolic profile can be understood in terms of a mea-
sure of selective advantage - a prescription derived from
Quantum Metabolism and evolutionary dynamics.
Darwinian fitness in somatic evolution
The concept Darwinian fitness describes the capacity of
a variant type to increase in frequency in competition
with an incumbent population for the available
resources. This notion is of fundamental importance in
all analytical studies of the Darwinian process at mole-
cular, cellular and organismic levels.
Studies of selective advantage in evolutionary pro-
cesses were pioneered by Fisher [35], who proposed the
population growth rate, denoted r, as the measure of
Darwinian fitness. According to Fisher, selective advan-
tage in evolutionary dynamics is given by
sr  (2)
Here, Δr=r *-r ,w h e r er* is growth rate of the var-
iant and incumbent type, respectively. These models
have provided qualitative insight into several studies of
the evolutionary process and since 1930 have been the
dominant approach in evolutionary genetics - in spite of
several inconsistencies in their predictive and explana-
tory power.
Measure of selective advantage: evolutionary entropy
The analytical and conceptual basis for the limitations of
the classical models proposed by Fisher, was only recently
recognized [35]. The studies reported in [15] showed that
the population growth rate as a measure of fitness is only
Table 1 Predominant energy metabolism in different
types of tumor cells
Tissue of Tumor Cell Type Predominant Energy
Metabolism
Brain Glioma Gly
Bone Sarcoma OxPhos
Colon Colon
adenocarcinomas
Gly
Lung Lung carcinoma Ox Phos
Skin Melanoma Ox Phos
Table 2 Glycolytic ATP contribution in selected normal
cell types.
Cell Type Percentage of Glycolytic ATP
contribution
Mouse macrophages 18
Pig platelets 57
Rat coronary endothelial cells 53
Human platelets 24
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sequently, the Malthusian parameter will only be a mean-
ingful selective index when population sizes are large.
The studies initiated by Demetrius [15] and later
developed as a general model of the evolutionary pro-
cess showed that the outcome of competition between
an incumbent and a variant type is conditional on the
magnitude and the variation in resource constraints, and
is predicted by the robustness or the demographic stabi-
lity of the population [36]. Robustness describes the rate
at which the population returns to its steady state con-
dition after a random perturbation in the individual
birth and death rates. This property can be analytically
described in terms of the quantity evolutionary entropy,
an information theoretic measure which describes the
uncertainty in the state - age, size, metabolic energy - of
the immediate ancestor of a randomly chosen newborn.
Evolutionary entropy in cellular populations describes
the variability in the rate at which individual cells pass
through the various stages of the cell cycle. A synchro-
nous population has small entropy, an asynchronous
population has large entropy.
Selective advantage in the context of this model is
given by
sN S   (/ )   (3)
Here, ΔS=S *-S , where S* and S represent the entropy
of the variant and the incumbent type, respectively. The
quantity F, the reproductive potential, and g,t h ed e m o -
graphic index, are statistical parameters which depend on
the survivorship and replication rate of the cells in the
population. These statistical parameters characterize cer-
tain measures of resource constraints, assuming that the
changes in the resource conditions are in dynamical equi-
librium with changes in the number of cells. The para-
meter F describes mean resource abundance and g the
variance in the resource abundance.
(i) F <0 corresponds to limited resource
(ii) F >0 corresponds to unlimited resource
and
(iii) g < 0 corresponds to a variable resource
distribution
(iv) g > 0 characterizes a constant resource
distribution
The measure of selective advantage given by Eq. (3) is a
far-reaching generalization of the measure given by Eq.
(2). Indeed, Eq. (3) reduces to Eq. (2) when g = 0 or when
the population size N tends to infinity. The condition g =
0 corresponds to a complete correlation between the
resource variability and the demographic variability.
In view of the characterization of the statistical para-
meters F and g as resource constraints, the measure of
selective advantage given by Eq. (3) can be roughly
described in terms of the following two tenets.
(Ia) When resources are constant and limited, variants
with increased entropy will have a selective advantage
and increase in frequency in competition with the resi-
dent type.
An increased entropy describes an increased capacity
to maintain a constant population size when subject to
random perturbations in the individual birth and death
rates. This stability condition confers a selective advan-
tage when resources are limited.
(Ib) When resources fluctuate in abundance, variants
with decreased entropy will have a selective advantage and
decrease in frequency in competition with the resident type.
A decreased entropy represents an increased sensitiv-
ity of population numbers to random perturbations in
the individual birth and death rates. This increased sen-
sitivity - which entails a decreased resilience or stability
- now confers a selective advantage when resources fluc-
tuate in abundance, as it enables the population to track
the changes in the resource abundance.
The importance of this measure of selective advantage
for the study of cellular evolution and the evolution of
cancer phenotype rests on the fact that evolutionary
entropy, a population parameter, is analytically related
to physiological and morphometric properties of indivi-
dual cells [37]. Consequently, the selective advantage
can be described in terms of changes in characteristics
such as metabolic rate and cell size.
Metabolic rate as fitness
The central result of quantum metabolism is the allo-
metric relation between metabolic rate and cell size
given by Eq. (1). An immediate consequence of this allo-
metric law is a scaling rule involving cycle time, τ,a n d
cell size W. This is given by
 ~
/( ) W
d 11  (4)
A fundamental result in studies of the macroscopic
parameters that characterize the population dynamic is
the relation between evolutionary entropy S and the
cycle time, τ, see Demetrius, Legendre and Harremöes
[37], namely:
Sa l o g  1  (5)
where a1 is a taxon specific constant. Eqs. (1), (4) and
(5) can be combined to derive a relation between meta-
bolic rate P and evolutionary entropy, namely:
S a b logP  22 (6)
where the taxon-specific constants a2 and b2are
positive.
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entropy and metabolic rate will be positively correlated.
This entails that the selective advantage given by Eq. (3)
can now be expressed in the form:
sN P   (/ )   (7)
This result asserts that the outcome of competition
between a resident and a variant cell type will be depen-
dent on the resource abundance, as described by F,t h e
resource variability, as expressed by g, and the metabolic
rate P.
The significance of metabolic rate in the description of
selective advantage, as given by Eq. (7), revolves around
the observation that cellular metabolic rate is con-
strained by two main factors: (a) the rate at which the
cells acquire resources, and (b) the rate at which
resources acquired are transformed into cellular work.
In this context, the rules describing the outcome of
competition between resident and variant types which
Eq. (7) prescribes, can be annotated in the following
terms.
(IIa) When resources are constant and limited, var-
iants with increased metabolic rate have a selective
advantage and increase in frequency in competition with
the resident type.
An increased metabolic rate entails an increased effi-
ciency in the acquisition of resources. This condition
will confer a selective advantage when resources are lim-
ited. Hence, when limited resource conditions prevail,
types with higher metabolic rates will be favoured.
(IIb) When resources vary in abundance, and the mean
abundance is large, resource density is no longer a limiting
constraint and types with decreased metabolic rate will
have a selective advantage and increase in frequency.
When the mean abundance is large, selective outcome
will no longer be contingent on the efficiency in
resource acquisition. The dynamics of selection will now
be determined by the capacity of cells to transform
resources into cellular work. In view of the allometric
relations between metabolic rate and cell size, cells with
decreased metabolic rates will typically have smaller
sizes; consequently their capacity to transform resources
into cellular activity will be enhanced. Therefore, under
abundant resource conditions cells with decreased meta-
bolic rate will prevail.
These general rules provide a basis for predicting
changes in metabolic profile as one cell type replaces a
related type by natural selection.
Metabolic rate is the rate of ATP production per unit
time. Metabolic efficiency is the amount of ATP pro-
duced per unit of substrate material. The metabolic rate
is the minimum rate at which the cell uses energy to
stay alive. All living systems exist in a steady state
relatively far from thermodynamic equilibrium and this
state is maintained by sustaining non-equilibrium con-
centration gradients across membranes. This activity
requires a constant influx of metabolic energy, and the
consequent generation of entropy. The ratio of the
energy stored in the various bio-molecules to the free
energy released in redox reactions is the efficiency of
the metabolic process, which can be as high as about
95% in the case of the Krebs cycle. This high efficiency
is characteristic of cyclic processes.
Our analysis rests on certain critical differences in the
metabolic rate of cells utilizing fermentation and
respiration. First, we observe that there are significant
differences in the metabolic efficiency between glycolysis
and OxPhos. The metabolism of glucose to lactate gen-
erates only 2 ATP (net) per molecule of glucose,
whereas OxPhos generates up to 38 ATP molecules
(net) [38]. Now, metabolic efficiency and metabolic rate
in cells are determined by the same processes and the
same reactions. Consequently, metabolic rate under gly-
colysis will be less than that under OxPhos. These
observations, together with the expression for selective
advantage given by Eq. (7), imply that the metabolic
profile - fermentation or respiration which defines a cell
type will be determined by the resource constraints the
populations experience during their evolutionary history.
We can, therefore, infer from the principles described
in (IIa) and (IIb) the following rules relating resource
constraints and the selective advantage of the two
classes of metabolic pathways.
(IIIa) When resources are constant and limited, cells
utilizing oxidative phosphorylation will have a selective
advantage.
(IIIb) When resources vary in abundance and the
mean abundance is large, cells utilizing the glycolytic
pathway will have a selective advantage.
These principles, which derive from the higher meta-
bolic efficiency of OxPhos, and concomitantly the higher
metabolic rate, provide an evolutionary explanation of
t h em o d eo fe n e r g yp r o c e s s i n go b s e r v e di nm i c r o b e s
and higher organisms. The principles given by (IIIa) and
(IIIb) entail that microbes and higher organisms will be
characterized by the OxPhos mode of energy processing
when evolving under limited resource conditions, and a
glycolytic mode when evolving under exponential
growth conditions.
Empirical observations on the metabolic phenotypes of
microbes and cells from multi-cellular organisms are
consistent with these predictions. Unicellular organisms
starved of nutrients respire aerobically, as is the case of
cells in multi-cellular organisms that are maintained in
a non-proliferative state. Unicellular organisms under-
going exponential growth metabolize glucose by fermen-
tation into a small organic molecule such as ethanol.
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similar metabolic profile: these cells utilize glycolysis
and excrete large amounts of lactate.
The selection principle based on metabolic rate can
also be cited to explain the use of aerobic glycolysis in
certain classes of cells, namely, neurons, retinal cells,
stem cells and germ cells. Aerobic glycolysis confers a
selective advantage in cells evolving under conditions
where the resources are abundant. Neurons, retinal cells
and stem cells require for their metabolic functioning, a
large resource energy. The presence of glycolysis as the
mode of energy processing is the selective outcome of
the environmental conditions under which these types
of cells evolve. These cells do not develop the cancer
phenotype since the energy which the cells absorb is
constantly being used to maintain the homeostatic
integrity of the organism.
The Warburg Effect: Competition between cancer cells
and normal cells
Quantum Metabolism predicts that differences in the
metabolic rate of cells using OxPhos and cells using gly-
colysis derive primarily from the differences in the
mode of coupling between the energy generated by the
flow of electrons in the electron transport chain and
ADP phosphorylation.
In OxPhos, the coupling is electrical and the meta-
bolic rate is determined by the flow of protons across
the mitochondrial inner membrane. In glycolysis, the
coupling is chemical and the metabolic rate is regulated
by the activity of the glycolytic enzymes.
Carcinogenesis is a multi-step process that implicates
the activation of oncogenes, the inactivation of tumor
suppressor genes and the ultimate emergence and prolif-
eration of the cancer phenotype. The transition to the
glycolytic phenotype of malignant cells which define the
Warburg effect is a consequence of an evolutionary pro-
cess. Our synthesis of Quantum Metabolism [14] and
evolutionary dynamics [15] establishes that the index of
selective advantage which describes this process is a
function of the resource constraints and the metabolic
rate of the competing cell types.
T h em e a s u r eo fs e l e c t i v ea d v a n t a g eg i v e nb yE q .( 7 )
entails that the outcome of competition between normal
cells, metabolizing the OxPhos pathway and cells using
glycolysis is a stochastic event contingent on the
resource density and distribution. The relation between
resource constraints and selective outcome is a conse-
quence of Eq. (7) and can be summarized in Table 3.
Table 3 underscores the stochastic nature of the out-
come of competition between the two types of cells and
consequently the stochastic nature of the evolution of
the glycolytic phenotype. The selective outcome depends
not only on the resource constraints but also on the
population size of the cells from which the tumor
originated. Items (III) and (IV) indicate that when the
population size is small, the selective outcome is highly
stochastic - a glycolytic phenotype may outcompete the
OxPhos pathway, even though the resources are limited;
and an OxPhos phenotype may prevail in competition
even though the resources are fluctuating. The stochas-
ticity which small population size generates - a property
emphasized in the general theoretical study in [36] -
indicates that when resources are limited tumor cells
may even invade a population of normal differentiated
cells.
The stochasticity which Table 3 delineates partly
explains the non-universality of the Warburg effect and
the caution which must be exercised in using the effect
as a basis for detecting cancer. Most but not all cancer
cells display the glycolytic phenotype.
Therapeutic Strategies
The Warburg hypothesis asserts that cancer is primarily
a disease of metabolic dysregulation. The activation of
oncogenes and the inactivation of tumor suppressor
genes have engineered alterations in metabolism and a
shift from an oxidative mode of energy processing to a
glycolytic mode [38].
This phenomenon suggests that therapeutic strategies
based on arresting the transition from a normal differ-
entiated cell defined by oxidative mode of energy pro-
cessing to a malignant cell defined by up-regulation of
glycolysis may be effective in complementing traditional
methods based on radiation and chemotherapy.
The evolutionary rationale for the shift to the up-regu-
lation of the glycolytic pathway has provided an under-
standing of the forces which drive cells towards
malignancies. Our analysis has implicated several
factors:
Table 3 Outcomes of competition between resident
population using OxPhos and mutant cells using
glycolysis.
Resource Constraints Selective Outcome
(I) Limited resources Ox Phos [(almost always) = (a.s.)]
Constant distribution
(II) Abundant resources Glycolysis (a.s.)
Variable Distribution
(III) Limited Resources
Variable distribution:
Large population size Ox Phos (a.s.)
Small population size Ox Phos (with probability that
increases with population size)
(IV) Abundant resources
Constant distribution
Large population size Glycolysis (a.s.)
Small population size Glycolysis (with probability that
increases with population size)
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cells utilize.
(2) The population size of the tumor cells.
(3) The relative metabolic rate of the normal and
tumor cells.
Our evolutionary study has discovered two critical fea-
tures of the competitive dynamics of tumor cells and
their normal ancestors.
(1) When resources are limited, the OxPhos pheno-
type, in view of its higher metabolic rate, will have a
selective advantage. Consequently, cells displaying the
glycolytic phenotype will have a relatively low probabil-
ity of becoming established and proliferating. In essence,
limited resource condition will inhibit the proliferation
of the cancer phenotype.
(2) When resources are abundant, the glycolytic phe-
notype, in view of its lower metabolic rate, will have a
selective advantage. Accordingly, cells displaying the gly-
colytic phenotype will have an enhanced probability of
becoming established. Hence an abundant resource flux
will facilitate the development of the cancer phenotype,
its invasiveness and metastases.
These observations suggest at least four distinct
classes of therapeutic strategies to contain the shift of
tumors towards the malignant state. These strategies are
based on various types of metabolic interventions, some
of which have been extensively investigated in the past
o b l i v i o u s ,h o w e v e r ,t ot h et h eoretical rationale which
quantum metabolism confers.
Modifying the metabolic rate of cancer cells
Cancer cells exploit the glycolytic pathway as the mode
of energy processing. The metabolic rate of cells using
this mode of energy processing is determined primarily
by the glycolytic enzymes [39 ] :h e x o k i n a s eH X K ,p h o s -
phofructokinase, (PFK), lactate dehydrogenase, (LDH),
Transketolase, (TKTL1). These enzymes are generally
up regulated in various cancer cells. This class of
enzymes represent potential therapeutic targets as the
modification of their activity will have significant effects
on the metabolic rate of cancer cells and hence their
selective advantage.
It is worth noting in this connection that the proton-
motive force across a membrane, Δp, is given by [36]
   p R T F p H  (. /) 23 (8)
where ΔΨ is the membrane potential, F denotes Fara-
day’sc o n s t a n ta n dΔpH is the change in pH across the
membrane. The values of Δp, ΔΨ and ΔpH depend on
the geometry and chemical composition of the energy
transducing membrane. Consequently, the metabolic
rates can be controlled by not only the membrane com-
positions and its geometry but also variations in tem-
perature and pH. One of the well-known characteristics
of cancer cells is their difference in pH (acidic) com-
pared to normal cells. Interestingly, cancer cells appear
to exhibit greater heat sensitivity than normal cells
which may also lead to therapeutic applications. Recent
biochemical and clinical studies have revealed a pro-
found and selective toxic effect of elevated temperatures
on tumor cells [40].
Modifying the metabolic rate of normal cells
The metabolic rate of normal cells is primarily deter-
mined by the proton conductance and the proton
potential of the metabolic systems. These bio-energetic
parameters are regulated by the phospholipid composi-
tion of the mitochondrial membrane. This composition
c a nb em o d i f i e db ye x e r c i s ea n dd i e t[ 4 1 ] .S u c hm o d i f i -
cation can increase the metabolic rate of normal cells,
thus enhancing its selective advantage, under limited
resource conditions, with cells utilizing the glycolytic
pathway.
It is also tantalizing to speculate about the high thera-
peutic value of metabolism-oriented drugs, such as the
recently headlined molecule dichloroacetic acid (DCA)
which attempts to restore OxPhos and hence mitochon-
drial function, ultimately restoring apoptosis which has
been demonstrated to kill cancer cells in vitro,a n d
shrink tumors in rats [42]. DCA is currently in clinical
trials and it is hoped that it may become the first effec-
tive drug in dealing with the glycolytic pathway activated
in cancers. A recent report [34] has shown that inhibi-
tion of glycolysis severely depletes ATP in cancer cells,
especially in clones of cancer cells with mitochondrial
respiration defects, and leads to rapid dephosphorylation
of the glycolysis-apoptosis integrating molecule BAD,
and cell death. Importantly, inhibition of glycolysis effec-
tively kills colon cancer cells and lymphoma cells in a
hypoxic environment in which the cancer cells exhibit
high glycolytic activity and decreased sensitivity to com-
mon anticancer agents.
Changing the cycle time using uncoupling agents and
inhibitors
Cycle time can be experimentally manipulated, for
instance, using uncoupling agents and inhibitors of elec-
tron transport. There are six distinct types of poisons
which may affect mitochondrial function [39]: (i)
respiratory chain inhibitors (e.g. cyanide, antimycin,
rotenone, TTFA, malonate) which block respiration in
the presence of either ADP or uncoupling agents; (ii)
phosphorylation inhibitors (e.g. oligomycin) which abol-
ish the burst of oxygen consumption; (iii) uncoupling
agents (e.g. DNP, CCCP, FCCP, oligomycin) which dis-
rupt the linkage between the respiratory chain and the
phosphorylation system; (iv) transport inhibitors (e.g.
atractyloside, bongkrekic acid, NEM) which either pre-
vent the export of ATP, or the import of raw materials
across the mitochondrial inner membrane; (v)
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inner membrane permeable to compounds which are
ordinarily unable to cross it; and (vi) Krebs cycle inhibi-
tors (e.g. arsenite, aminooxyacetate) which block one or
more of the TCA cycle enzymes, or an ancillary
reaction.
According to Quantum Metabolism, changing the
cycle time can induce a change of the scaling exponent
b [14] which, in turn, will affect the metabolic rate of
the cell type. This can further alter the selective advan-
tage of tumor cells and thereby impede the transition to
a malignant state. However, the toxicity of these com-
pounds makes clinical applications to cancer therapy
very challenging, except perhaps for the arsenic com-
pounds. Hence novel uncoupling agents are still much
in demand.
Discussion and Conclusions
These differences in the factors that determine meta-
bolic rate in the two modes of energy processing have
been exploited to explain certain aspects of the Warburg
effect and the selective advantage of the glycolytic phe-
notype. The understanding of the metabolic basis of car-
cinogenesis which this evolutionary study generates
suggests new methods for regulating cellular metabolic
rate and thereby impeding the transition from a benign
tumor to a malignant state. In this connection, it is
interesting to note that Western diet which is very cal-
orie-rich confers evolutionary advantage to cancer cells
hence the increased incidence of cancer in North Amer-
ica and Europe compared to developing countries.
Furthermore, increased longevity contributes to this
effect as well, since it is well-known that the metabolic
rate decreases with age of individuals and in the West
the caloric intake does not fall with age at the same rate
providing an additional factor for the growth of tumors.
Quantum metabolism, a new bio-energetic theory of
metabolic regulation in cells, shows that the proportion-
ality constants in the scaling laws for metabolic rates of
cells utilizing OxPhos and glycolysis pathways are con-
tingent on the different modes of coupling between the
electron transfer chain and ADP phosphorylation.
(1) In OxPhos, the coupling between the redox reac-
tions (in the mitochondria) and ADP phosphorylation is
electrical. Hence the metabolic rate is determined by
bio-energetic parameters such as the proton conduc-
tance and proton potential of the metabolic network.
(2) In glycolysis, ADP phosphorylation is linked che-
mically to individual enzyme-catalyzed reactions, so the
rate of ATP production is a function of the flux through
the pathway as a whole.
Detailed analysis of internal regulation of ATP turn-
over through both glycolysis and oxidative phosphoryla-
tion in terms of specific biochemical mechanisms has
been presented in [43,44] in the context of normal cells.
Metabolic interventions which focus on modulating the
efficiency of these modes of coupling should provide a
general framework for regulating the incidence of these
two modes of energy processing - and thereby yield a
new paradigm for cancer therapy [45]. A recent article
[46] has advocated a combination therapy utilizing vita-
mins as a strategy aimed at energy modulation in cancer
leading to the prevention of life-limiting cachexia.
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